## Objective: The aims of this study were to (a) determine the factor structure of the behavioral pathology in alzheimer's disease scale (behave-ad), and (b) examine the associations of the observed factors to the level of cognitive impairment. ## Design: Cross-sectional study of geriatric patien
The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients
β Scribed by Michal Schnaider Beeri; Perla Werner; Michael Davidson; Shlomo Noy
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 65 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.490
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Introduction
Behavioral and psychological symptoms of dementia (BPSD) are highly prevalent in Alzheimer's disease (AD) patients. They are a source of distress for the caregivers and one of the main reasons for nursing home placement, which is the major component of the cost of Alzheimer's disease. The aim of the present study was to assess the direct and indirect cost related to the care of BPSD within a prospective study examining the overall cost of AD in Israel.
Methods
Seventyβone community dwelling AD patients were interviewed. Interviews covered information about the number of caregivers' hours invested in caring for the patient and amount of expenditure such as inβhouse paid help and payments for day care. Effort devoted to BPSD was defined as the number of hours spent by primary and secondary caregivers in a typical week dealing with BPSD (managing aggression, pacing, attempts to leave the house under inappropriate circumstances, or comforting a hallucinating, depressed or anxious patient).
Results
The annual indirect cost for management of BPSD in an AD patient was approximately $2665βover 25% of the total annual indirect cost of care ($10β520). The annual direct cost of BPSD of an AD patient was approximately $1450βover 35% of the total annual direct cost of care ($3900).
Conclusions
Approximately 30% ($4115) of the total annual cost of AD ($14β420) is invested in the direct management of BPSD. Given the importance of BPSD as one of the main components of the cost of AD, future cost studies should be designed to measure the cost of specific components of BPSD and verify which are the most costly aspects of the disease. Despite the considerable methodological difficulties in disentangling the costs of the specific symptoms of AD, cost effectiveness studies of different interventions should be conducted in order to determine the optimal intervention with relation to cost. Copyright Β© 2002 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract Behavioral and psychological symptoms in dementia (BPSD) are very common, with 90% of patients experiencing at least one during the course of the disease. Oneβthird of persons with dementia have depressive symptoms, and concomitant BPSD are very likely. ## Objective This study aimed t
## Abstract ## Background When comparing with earlyβonset Alzheimer's disease (EOβAD) and lateβonset Alzheimer's disease (LOβAD), some symptomatological differences in clinical features can be seen between them. Rapid progression, more severe language problems or visuospatial dysfunction occur mor
## Abstract ## Background This study aimed (1) to compare the behavioral and psychological symptoms of dementia (BPSD) between patients with Alzheimer's disease (AD) and vascular dementia (VaD); (2) to investigate the differences in the correlates of BPSD between them; and (3) to suggest potential
## Objective: This cross-sectional study examined the relationship of behavioral and psychological symptoms to cognitive and functional impairment in alzheimer's disease (ad). ## Design: One hundred and fourteen patients were evaluated consecutively at a university-affiliated outpatient memory di